Luminera Pharm

Luminera is an Israeli R&D company specializing in the development and manufacture of innovative medical devices in the field of aesthetic medicine. The company's portfolio includes a wide range of dermal fillers based on hyaluronic acid and calcium hydroxylapatite, such as Crystalys, Hydryalix, and HArmonyCa. Luminera is recognized for its proprietary Moisturizing Homogenous Synergy (MHS) technology, which creates smooth, monophasic gels for natural-looking aesthetic results. In 2020, the company was acquired by Allergan Aesthetics, a subsidiary of AbbVie, significantly expanding its global reach and integrating its hybrid filler technology into the Juvederm portfolio.